Brief: Alembic Pharma Says USFDA Approval For Paliperidone Extended-Release Tablets
27/09/2024 08:35
Sept 27 (Reuters) - Alembic Pharmaceuticals Ltd
ALEM.NS :
* RECEIVES USFDA FINAL APPROVAL FOR PALIPERIDONE
* USFDA APPROVAL FOR PALIPERIDONE EXTENDED-RELEASE TABLETS,
1.5
MG, 3 MG, 6 MG, 9 MG
Source text for Eikon: ID:nNSE4lZ54T
Further company coverage: ALEM.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand